Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Young onset Alzheimer’s disease (YOAD) is defined as symptom onset before the age of 65, and is particularly associated with phenotypic heterogeneity. Atypical presentations, such as the clinic-radiological visual syndrome Posterior Cortical Atrophy (PCA), often lead to delays in accurate diagnosis. Eyetracking has been used to demonstrate basic oculomotor impairments in individuals with dementia. In the present study, we aim to explore the relationship between eyetracking metrics and standard tests of visual cognition in individuals with YOAD. Fifty-seven participants were included: 36 individuals with YOAD (n=26 tAD; n=10 PCA) and 21 age-matched healthy controls. Participants completed three eyetracking experiments: fixation, pro-saccade and smooth pursuit tasks. Summary metrics were used as outcome measures and their predictive value explored looking at correlations with visuoperceptual and visuospatial metrics. Significant correlations between eyetracking metrics and standard visual cognitive estimates are reported. A machine learning approach using a classification method based on the smooth pursuit raw eyetracking data, discriminates with approximately 95% accuracy patients and controls in cross-validation tests. Results suggest that the eyetracking paradigms of a relatively simple and specific nature provide measures not only reflecting basic oculomotor characteristics, but also predicting higher order visuospatial and visuoperceptual impairments. Eyetracking measures can represent extremely useful markers during the diagnostic phase and may be exploited as potential outcome measures for clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
Self-citationRevising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869
Self-citationPhase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668 · cited 1×
“org August 2017 | Volume 8 | Article 377 disease-modifying treatments available for AD (6, 7).”
BackgroundConsensus classification of posterior cortical atrophy
Crutch, S. J., Schott, J. M., Rabinovici, G. D., Murray, M., Snowden, J. S., van der Flier, W. M., Dickerson, B. C., Vandenberghe, R., Ahmed, S., Bak, T. H., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.014 · Cited by 665
Self-citationGauthier, S., Feldman, H. H., Schneider, L. S., Wilcock, G. K., Frisoni, G. B., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Wischik, D. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31275-2 · Cited by 427
Vision and cognition in Alzheimer’s disease
Rizzo, M. (2000) · Neuropsychologia · doi:10.1016/s0028-3932(00)00023-3 · Cited by 308
Age at onset and visuocognitive disturbances in Alzheimer disease.
Fujimori, M., Imamura, T., Yamashita, H., Hirono, N., Ikejiri, Y., Shimomura, T., & Mori, E. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199809000-00007 · Cited by 72
Cited by
Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity
Kourtis, L. C., Regele, O. B., Wright, J. M., & Jones, G. B. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0084-2 · Cited by 476
Alzheimer's disease digital biomarkers multidimensional landscape and AI model scoping review
Qi, W., Zhu, X., Wang, B., Shi, Y., Dong, C., Shen, S., Li, J., Zhang, K., He, Y., Zhao, M., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01640-z · Cited by 78
Immersive Virtual Reality-Based Methods for Assessing Executive Functioning: Systematic Review
Kirkham, R., Kooijman, L., Albertella, L., Myles, D., Yücel, M., & Rotaru, K. (2024) · JMIR Serious Games · doi:10.2196/50282 · Cited by 40
“For example, pupillometry can offer insights into brain injury prognosis [94] and differentiate between participants with Alzheimer disease and healthy controls [95].”
Background
Metadata
- Authors
- Pavisic, I. M., Firth, N. C., Parsons, S., Rego, D. M., Shakespeare, T. J., Yong, K. X. X., Slattery, C. F., Paterson, R. W., Foulkes, A. J. M., Macpherson, K., Carton, A. M., Alexander, D. C., Shawe-Taylor, J., Fox, N. C., Schott, J. M., Crutch, S. J., & Primativo, S.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2017-08-07
- Volume
- 8
- Pages
- 377-377
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W2743629169
- Cited by
- 96
- References
- 9
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions. https://app.cochat.ai/papers/10.3389/fneur.2017.00377
- The paper
- Pavisic, I. M., Firth, N. C., Parsons, S., Rego, D. M., Shakespeare, T. J., Yong, K. X. X., Slattery, C. F., Paterson, R. W., Foulkes, A. J. M., Macpherson, K., Carton, A. M., Alexander, D. C., Shawe-Taylor, J., Fox, N. C., Schott, J. M., Crutch, S. J., & Primativo, S. (2017). Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions. Frontiers in Neurology. https://doi.org/10.3389/fneur.2017.00377
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.